
Bioceres Crop Solutions ( ($BIOX) ) has issued an announcement. On September 18, 2026, Bioceres Crop Solutions disclosed that the Supreme Court of the State of New York granted a
Compare up to 40 stocks
Compared Stocks: 1 / 40
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| BIOX | Bioceres Crop Solutions | 0.19 | -1.30 | -87.12% |
| Name | Price | % Change | |
|---|---|---|---|
| $0.19 | -87.12% |

Bioceres Crop Solutions ( ($BIOX) ) has issued an announcement. On September 18, 2026, Bioceres Crop Solutions disclosed that the Supreme Court of the State of New York granted a

Bioceres Crop Solutions ( ($BIOX) ) has shared an update. On September 14, 2026, Bioceres Crop Solutions reported fiscal fourth-quarter revenues of $55.9 million, broadly flat year-on-year, and full-year revenues

Bioceres Crop Solutions (($BIOX)) has held its Q4 earnings call. Read on for the main highlights of the call. Bioceres Crop Solutions’ latest earnings call struck a cautiously constructive tone

Reports Q4 revenue $55.9M vs. $55.4M last year. Mr. Federico Trucco, Bioceres (BIOX)’ Chief Executive Officer, commented: “Fiscal 2026 was a challenging year for Bioceres, marked by the ongoing litigation

Bioceres Crop Solutions ( ($BIOX) ) has provided an update. Bioceres Crop Solutions updated its fiscal third-quarter 2026 results on June 19 after recording an additional provision of about $3.4

Bioceres Crop Solutions ( ($BIOX) ) just unveiled an update. On May 29, 2026, Rizobacter Argentina, a subsidiary of Bioceres Crop Solutions, announced it had successfully completed an exchange offer

Bioceres Crop Solutions (($BIOX)) has held its Q3 earnings call. Read on for the main highlights of the call. Bioceres Crop Solutions’ latest earnings call struck a cautious tone, balancing

Bioceres Crop Solutions (($BIOX)) has held its Q3 earnings call. Read on for the main highlights of the call. Bioceres Crop Solutions’ latest earnings call struck a cautious tone, blending

Bioceres Crop Solutions ( ($BIOX) ) has provided an announcement. Bioceres Crop Solutions reported fiscal third-quarter 2026 results on May 11, 2026, with revenues from continuing operations falling 23% year

Reports Q3 revenue $39.4M, one estimate $54.5M. Mr. Federico Trucco, Bioceres (BIOX)’ Chief Executive Officer, commented: “This quarter reflects a period of transition and operational refocusing for the Company. While
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| hold | Reiterated | Dec 31, 2025 |
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| May 13, 2027TBA | $12.74M | ― | ― | 0.05 | -0.06 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.